4//SEC Filing
Raptor Pharmaceutical Corp 4
Accession 0001140361-15-025097
CIK 0001070698operating
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 9:57 PM ET
Size
10.5 KB
Accession
0001140361-15-025097
Insider Transaction Report
Form 4
Daley Thomas E
Other
Transactions
- Sale
Common Stock
2015-06-18$15.00/sh−5,000$75,000→ 34,719 total - Exercise/Conversion
Common Stock
2015-06-18+5,000→ 62,864 totalExercise: $3.54Exp: 2020-11-22→ Stock options (right to buy) (5,000 underlying) - Exercise/Conversion
Common Stock
2015-06-18$3.54/sh+5,000$17,700→ 39,719 total - Sale
Common Stock
2015-06-18$15.00/sh−30,000$450,000→ 34,719 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 26, 2014.
- [F2]Includes 11,500 Restricted Stock Units ("RSUs") granted on February 9, 2015. The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof.
- [F3]Fully vested and exercisable.
Documents
Issuer
Raptor Pharmaceutical Corp
CIK 0001070698
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070698
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 9:57 PM ET
- Size
- 10.5 KB